Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Clinical trial NCT02701205 · UNKNOWN
Trial details
- NCT number
- NCT02701205
- Sponsor
- Shanghai Celgen Bio-Pharmaceutical Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-01-01
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.